|
Published by: Infiniti Research Limited
Published: Nov. 9, 2012 - 45 Pages
Table of Contents- 1. Executive Summary
- 2. Introduction
- 3. Market Coverage
- Overview
- Key Offerings
- 4. Market Landscape
- 4.1 Global Enzyme Inhibitors Market
- 4.2 Market Segmentation
- 4.3 Global Kinase Inhibitors Market
- 4.4 Five Forces Analysis
- 5. Geographical Segmentation
- 6. Vendor Landscape
- Vendor Ranking
- 7. Buying Criteria
- 8. Market Growth Drivers
- 9. Drivers and their Impact
- 10. Market Challenges
- 11. Impact of Drivers and Challenges
- 12. Market Trends
- 13. Key Vendor Analysis
- 13.1 AstraZeneca plc
- Business Overview
- Key Information
- SWOT Analysis
- 13.2 Merck and Co. Inc.
- Business Overview
- Key Information
- SWOT Analysis
- 13.3 Novartis AG
- Business Overview
- Key Information
- SWOT Analysis
- 13.4 Pfizer Inc.
- Business Overview
- Key Information
- SWOT ANALYSIS
- 13.5 Roche Holdings Ltd.
- Business Overview
- Key Information
- SWOT Analysis
- Other Reports in this Series
- List of Exhibits:
- Exhibit 1: Global Enzyme Inhibitors Market 2011–2015 (US$ billion)
- Exhibit 2: Global Enzyme Inhibitors Market Segmentation
- Exhibit 3: Global Enzyme Inhibitors Market Segmentation 2011
- Exhibit 4: Global Enzyme Inhibitors Market 2011–2015 (US$ billion)
- Exhibit 5: Global Kinase Inhibitors market by Geographical Segmentation 2011
- Exhibit 6: Vendor Ranking in Global Kinase Inhibitor Market 2011
AbstractTechNavio's analysts forecast the Global Kinase Inhibitor market to grow at a CAGR of 6.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the prevalence of disease. The Global Kinase Inhibitor market has also been witnessing the trend of an increase in the number of mergers and acquisitions. However, patent expiration of kinase inhibitors could pose a challenge to the growth of this market.
TechNavio's report, the Global Kinase Inhibitor Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Kinase Inhibitor market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are AstraZeneca plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Roche Holding Ltd.
The other vendors mentioned in the report are Takeda Pharmaceutical Co. Ltd., GlaxoSmithKline plc, Eli Lilly and Co., Abbott Laboratories Inc., Amgen Inc., Bayer AG, Johnson & Johnson Ltd., Sanofi S.A., Eisai Inc., Bristol-Myers Squibb Co., Boehringer Ingelheim GmbH, Mylan Inc., Teva Pharmaceutical Industries Ltd., and Ranbaxy Laboratories Ltd.
Key questions answered in this report:- What will the market size be in 2015 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
Get full details about this report >>
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports,
company profiles and country profiles from over 720 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
|
